NIH-funded research NIH-funded research

HIV and liver circadian rhythms: how co-infections affect liver health

Official title: Impact of HIV co-infections and comorbidities on circadian rhythm in the liver

Funded at Emory University · NIH-11345952 · Data updated 2026-11-12

This project explores how HIV-related infections and liver conditions interact with our body’s clock to influence liver disease in people living with HIV.

More Circadian Rhythm research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startAugust 15, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$540,074
NIH project number5DP1DK139804-03
Project IDNIH-11345952 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people living with HIV who may also have HBV co-infection or fatty liver disease, and who could participate in future translational studies or related trials.

Less likely to help

Individuals without HIV or without liver complications may not directly benefit from this specific research.

What this research studies

Researchers will study liver biology in cell culture and animal models to understand how HIV and hepatitis B, plus fatty liver disease, may disrupt circadian rhythms and worsen liver damage. They will examine how clock genes and metabolic pathways change when HIV-related infections are present and how this affects drug metabolism and liver health. The goal is to identify mechanisms that link circadian disruption with liver complications in HIV, which could point to new ways to prevent or treat these problems.

Why it matters

Potential benefit: If successful, the work could lead to better timing of medications and new strategies to protect liver health in people with HIV and co-infections.

How similar studies have gone: Previous research suggests circadian rhythms influence liver disease and antiviral drug metabolism, with growing evidence in HIV-related contexts.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Michailidis, Eleftherios — Emory University
  • Study coordinator: Michailidis, Eleftherios

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.